about
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Concise review: in search of unlimited sources of functional human pancreatic beta cellsMonitoring C-Peptide Storage and Secretion in Islet β-Cells In Vitro and In Vivo.Incomplete Re-Expression of Neuroendocrine Progenitor/Stem Cell Markers is a Key Feature of β-Cell Dedifferentiation.β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells.Adipsin is an adipokine that improves β cell function in diabetes.Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies.Bimodal effect on pancreatic β-cells of secretory products from normal or insulin-resistant human skeletal musclePartial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes.PKA Enhances the Acute Insulin Response Leading to the Restoration of Glucose Control.Coupling of metabolic, second messenger pathways and insulin granule dynamics in pancreatic beta-cells: a computational analysisL-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway.β-cell dysfunction in adolescents and adults with newly diagnosed type 2 diabetes mellitusEffects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus.The new biology of diabetes.Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetesβ-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretionDisruption of O-linked N-Acetylglucosamine Signaling Induces ER Stress and β Cell Failure.FoxO1 Deacetylation Decreases Fatty Acid Oxidation in β-Cells and Sustains Insulin Secretion in Diabetes.Inactivation of specific β cell transcription factors in type 2 diabetes.Long-term activation of PKA in β-cells provides sustained improvement to glucose control, insulin sensitivity and body weightBasal insulin: beyond glycemia.Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes.Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family.Islet function in obese adolescents.Progression of β-cell dysfunction in obese youth.The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors.Targeting the pancreatic β-cell to treat diabetes.Combination immunotherapies for type 1 diabetes mellitus.Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.The past 10 years-new hormones, new functions, new endocrine organs.Extracellular acidification stimulates GPR68 mediated IL-8 production in human pancreatic β cells.Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in db/db Mice.Characterization of stimulus-secretion coupling in the human pancreatic EndoC-βH1 beta cell line.Shaping and preserving β-cell identity with microRNAs.
P2860
Q22241288-B7263DC0-F299-41D4-AB57-1FDC79C0E64AQ26999928-D25DFFAD-9BB9-46DC-856E-D20E798429DFQ30277941-26CAE4C3-4996-4343-AC50-9EA349EF21F8Q30395715-C91A8EE8-97D9-47DF-AD64-7AA092EF1A49Q33570085-23D3DD7D-DC1A-43BD-8134-2C733E6EF808Q33756959-4274242A-9E8F-42AF-BB46-855B1F5AE489Q34025740-F4E699F8-314D-4274-B130-EA15027DEB6FQ34104455-53F758EA-640D-47C8-9A69-6912C4DF111EQ34718673-4D260A6E-3F2A-4C8B-9033-7C198E598988Q34718921-85C02DD9-19B8-4A29-A3AE-B3FC795EA699Q35132429-A2B8CEDE-9753-4FF0-8560-166BC7388E73Q35532241-D378D2D2-067C-47DB-93FF-87C41EFE1EA2Q35630344-B8528199-BFA1-4A9F-B852-ACEDC98845CEQ35696480-B22B92AC-A778-403C-A15A-664E0E3E5082Q35922968-33F9304A-54B9-46EC-899C-429086A6E074Q35976493-CE1DA97A-8B1F-4AB8-B6DA-04BCAE8AF290Q36113537-704DF244-0EC4-464A-9AA5-FC328F97A65DQ36241895-31BB64AB-6400-4E27-B67E-6307A7ADBC25Q36716120-5C9DE2C7-18B6-4AE6-9AD0-31E3BD771B0DQ36796140-5C3F8EDE-22A4-4739-9C39-C1B426E54036Q36820103-251F9D13-C248-4F9A-AD3B-7F89079E1478Q36876191-3432CE93-AD70-4DE4-8C8A-986FBF5F13F4Q37052883-1D37525E-CC9C-4304-951F-EE3E94CF72ECQ37268207-3F31F851-4F04-496D-A25F-1618E2523969Q37890775-8D0EE2F7-B541-450B-A53C-C1976DD5E9E1Q37955877-438153D6-4078-4F04-BA97-27A6AEAD0A04Q37981884-E4229113-5A25-444E-9EA2-40B5770CF809Q37996460-D010C6E8-5BA4-4135-92DF-7C826D88EC36Q38034273-35CDEAC6-4147-4EB5-95AB-090CE1E86FBCQ38038650-241DEC21-3BD1-42BA-BF6E-78AD03EDD00DQ38062439-0D5F47A6-3553-40F1-90F7-6A7DBB6187E3Q38126109-60E3054E-3E6D-4E0A-8560-73D8CF472873Q38187862-9DC40F35-575E-4F31-9D5F-E07ED7DD4121Q38358009-68C29A40-D569-4172-A686-0D21B51E870CQ38524435-DB801583-1E9B-430C-A449-28292027081FQ38577490-43193972-3EEE-4622-B6F5-1737688F2B85Q38771827-82B6C070-A4FF-4595-AA10-DF701B70EB72Q38784851-CBC7B3DC-DBFF-49DC-A7BD-0D24C42FF77DQ38895795-07B7E760-4C6A-4D01-98FF-D383C786C537Q38951150-86D9B465-79C8-4356-804F-5FA00C76ECF6
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The stunned beta cell: a brief history.
@en
The stunned beta cell: a brief history.
@nl
type
label
The stunned beta cell: a brief history.
@en
The stunned beta cell: a brief history.
@nl
prefLabel
The stunned beta cell: a brief history.
@en
The stunned beta cell: a brief history.
@nl
P1433
P1476
The stunned beta cell: a brief history.
@en
P2093
Ele Ferrannini
P304
P356
10.1016/J.CMET.2010.04.009
P577
2010-05-01T00:00:00Z